Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease

被引:29
|
作者
Andersen, Charlotte U. [1 ]
Mellemkjaer, Soren [2 ]
Nielsen-Kudsk, Jens Erik [2 ]
Bendstrup, Elisabeth [3 ]
Simonsen, Ulf [1 ]
Hilberg, Ole [3 ]
机构
[1] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Resp Dis & Allergol, Aarhus, Denmark
关键词
Biomarkers; Lung fibrosis; NT-proBNP; Troponin-T; fibrin D-dimer; BRAIN NATRIURETIC PEPTIDE; ARTERIAL-HYPERTENSION; HEART-FAILURE; TROPONIN-T; FIBROSIS; MARKER; PREVALENCE;
D O I
10.1016/j.rmed.2012.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Pulmonary hypertension (PH) is an important complication to interstitial lung disease (ILD). The aim of the present study was to investigate the relation of NT-proBNP, fibrin D-dimer, troponin-T, uric acid and exhaled nitric oxide (NO) to the presence of PH and mortality in ILD. Methods: In a previously described cohort of 212 ILD patients of whom 29 had PH, levels of the above mentioned biomarkers were analyzed as routine tests. Results: A value of NT-proBNP below 95 ng/l had a negative predictive value for PH of 99% (95% Cl: 94-100). Values of troponin-T were higher in patients with PH (median (inter quartile range) = 9 (9-20) vs. 9(9-10) ng/l), and the odds ratio (OR) for PH was increased in patients with abnormal levels of uric acid (OR (95% Cl) = 3.1(1.1-8.8)). NT-proBNP and troponin-T values above the 50th percentile, and uric acid and fibrin D-dimer values above the 90th percentile were each associated with increased mortality. Conclusions: A value of NT-proBNP below 95 ng/l may be used as a rule-out test for PH in ILD, while an abnormal value of uric acid is a risk factor for PH. NT-proBNP, troponin-T, uric acid and fibrin D-dimer have prognostic value in ILD patients, while exhaled levels of NO do not seem to predict PH or mortality. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1749 / 1755
页数:7
相关论文
共 50 条
  • [1] Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease
    Watase, Mayuko
    Mochimaru, Takao
    Kawase, Honomi
    Shinohara, Hiroyuki
    Sagawa, Shinobu
    Ikeda, Toshiki
    Yagi, Shota
    Yamamura, Hiroyuki
    Matsuyama, Emiko
    Kaji, Masanori
    Kurihara, Momoko
    Sato, Midori
    Horiuchi, Kohei
    Watanabe, Risa
    Nukaga, Shigenari
    Irisa, Kaoru
    Satomi, Ryosuke
    Oyamada, Yoshitaka
    PLOS ONE, 2023, 18 (03):
  • [2] Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
    Chin, Matthew
    Johns, Christopher
    Currie, Benjamin J.
    Weatherley, Nicholas
    Hill, Catherine
    Elliot, Charlie
    Rajaram, Smitha
    Wild, Jim M.
    Condliffe, Robin
    Bianchi, Stephen
    Kiely, David G.
    Swift, Andrew J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [3] Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation
    Sato, Tomonori
    Furukawa, Taiki
    Teramachi, Ryo
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Matsuda, Toshiaki
    Kataoka, Kensuke
    Kimura, Tomoki
    Kondoh, Yasuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [4] Diagnostic accuracy of echocardiography in pulmonary hypertension due to interstitial lung disease
    Heinze, Charlotte
    Richter, Manuel
    Sommer, Natascha
    Tello, Khodr
    Ghofrani, Hossein Ardeschir
    Seeger, Werner
    Gall, Henning
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [5] Pulmonary hypertension in interstitial lung disease
    Strange, C
    Highland, KB
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 452 - 455
  • [6] Pulmonary hypertension in interstitial lung disease
    Behr, J.
    Ryu, J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) : 1357 - 1367
  • [7] Pulmonary Hypertension in Interstitial Lung Disease
    Baldi, Bruno Guedes
    Souza, Rogerio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 685 - 686
  • [8] Pulmonary hypertension in interstitial lung disease
    Polomis, David
    Runo, James R.
    Meyer, Keith C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (05) : 462 - 469
  • [9] Pulmonary hypertension in interstitial lung disease
    Nathan, S. D.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 : 21 - 28
  • [10] Diagnostic Predictors Of Pulmonary Hypertension-Associated Mortality In Interstitial Lung Disease
    Adegunsoye, A.
    Chung, J. H.
    Montner, S.
    Narang, N.
    Lee, C. T.
    Witt, L. J.
    Oldham, J. M.
    Chen, L.
    Hsu, S.
    Bag, R.
    Husain, A.
    Noth, I.
    Vij, R.
    Strek, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195